TUBERCULOSIS IN LIVER TRANSPLANT RECIPIENT : A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.53555/nnmhs.v9i7.1772Keywords:
Immunocompromised, Isoniazid, Liver transplant, TuberculosisAbstract
Background: Despite claims, transplant recipients' TB rates are random. The rate of posttransplant tuberculosis depends on the organ transplanted, pre-transplant latent tuberculosis screening, and previous antituberculosis medication. This rate may also depend on recipient and donor tuberculosis rates. Active tuberculosis after solid organ transplantation increases the risk of graft loss and death four-fold compared to the general population.
Aim: This article examines the link between tubercolis and liver transplant recipient.
Methods: This study showed that it met all of the requirements by looking at the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020 guidelines. So, the experts could make sure that the study was as current as possible. The search method used a number of electronic reference databases, such as Pubmed and SagePub, to look for papers that were published between 2000 and 2023. We didn't look at review papers, articles that had already been published, or articles that were only half done.
Result: In the PubMed database, the results of our search brought up 66 articles, whereas the results of our search on SagePub brought up 23 articles. The results of the search conducted for the last year of 2013 yielded a total of 23 articles for PubMed and 18 articles for SagePub. In the end, we compiled a total of 20 papers, 16 of which came from PubMed and four of which came from SagePub. We included five research that met the criteria.
Conclusion: Patients who have undergone organ transplantation are at high risk of developing latent TB. This shows the importance of administering prophylactic drugs such as isoniazid in post-liver transplant patients.
References
1. WHO. Global Tuberculosis Report 2019. 2019.
2. Schwartz N, Price S, Pratt R. Tuberculosis - United States. Morb Mortal Wkly Rep. 2020;69(11):286–9.
3. WHO. Global tuberculosis report 2021 [Internet]. World Health Organization. 2021. Available from: https://www.who.int/publications/digital/global-tuberculosis-report-2021
4. Chiang SS, Starke JR. 134 - Mycobacterium tuberculosis. In: Long SS, Prober CG, Fischer MBT-P and P of PID (Fifth E, editors. Elsevier; 2018. p. 790-806.e5. Available from: https://www.sciencedirect.com/science/article/pii/B9780323401814001341
5. Dumra H. Tuberculosis in special situations: Co-morbid conditions, physiological states and contraception. Astrocyte [Internet]. 2017 Jul 1;4(2):100–7. Available from: http://www.astrocyte.in/article.asp?issn=2349-0977
6. Holty J-EC, Gould MK, Meinke L, Keeffe EB, Ruoss SJ. Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2009 Aug;15(8):894–906.
7. Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis an Off Publ Infect Dis Soc Am. 2017 Jan;64(2):111–5.
8. Fishman JA, Grippi MA, Kotloff RM, et al. Fishman’s Pulmonary Disease and Disorders Fifth Edition. New York: Elsevier Saunder; 2016.
9. Fishman JA, Greenwald MA, Grossi PA. Transmission of infection with human allografts: essential considerations in donor screening. Clin Infect Dis. 2012;55(5):720–7.
10. Malani PN. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Jama. 2010;304(18):2067–71.
11. Kim S-H, Oh S, Nham E, Ko J-H, Huh K, Cho SY, et al. Risk Groups of Developing Active Tuberculosis in Liver Transplant Recipients in a Tuberculosis Endemic Area: Risk Stratification by Chest Image and Interferon Gamma Release Assay. Int J Infect Dis [Internet]. 2021;113:359–66. Available from: https://www.sciencedirect.com/science/article/pii/S1201971221008286
12. Ahmadinejad Z, Mokhtaryan M, Salami A, Talebian M, Irajian H, Ghiasvand F. Evaluation of latent tuberculosis infection in liver transplant recipients. Iran J Microbiol. 2021 Apr;13(2):199–203.
13. Leong L-Y, Lin P-C, Chi C-Y, Chou C-H, Lu M-C, Liao W-C, et al. Risk factors of tuberculosis after liver transplant in a tertiary care hospital. J Microbiol Immunol Infect [Internet]. 2021;54(2):312–8. Available from: https://www.sciencedirect.com/science/article/pii/S1684118219301392
14. Olithselvan A, Rajagopala S, Vij M, Shanmugam V, Shanmugam N, Rela M. Tuberculosis in liver transplant recipients: Experience of a South Indian liver transplant center. Liver Transplant [Internet]. 2014 Aug 1;20(8):960–6. Available from: https://doi.org/10.1002/lt.23903
15. Liu J, Yan J, Wan Q, Ye Q, Huang Y. The risk factors for tuberculosis in liver or kidney transplant recipients. BMC Infect Dis [Internet]. 2014;14(1):387. Available from: https://doi.org/10.1186/1471-2334-14-387
16. Liu Y-C, Wu C-J, Ko P-S, Chien S-H, Fan N-W, Wang H-Y, et al. Mycobacterial infections in adult recipients of allogeneic hematopoietic stem cell transplantation: a cohort study in a high endemic area. J Microbiol Immunol Infect. 2020;53(2):274–82.
17. Subramanian A, Dorman S. Mycobacterium tuberculosis in solid organ transplant recipients. Am J Transplant. 2009;9(s4).
18. Lee JY. Diagnosis and treatment of extrapulmonary tuberculosis. Tuberc Respir Dis. 2015;78(2):47–55.
19. Organization WH. WHO operational handbook on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection. 2021;
20. Klein DJ, Boukouvala S, McDonagh EM, Shuldiner SR, Laurieri N, Thorn CF, et al. PharmGKB summary: isoniazid pathway, pharmacokinetics (PK). Pharmacogenet Genomics. 2016;26(9):436.
21. GOVIL S, SATSANGI S, REDDY J, RAGHAVAIAH S, SWAMINATHAN S. The potential liver donor with tuberculosis: A fresh look at international recommendations based on a survey of practice in Indian liver transplant centres. Natl Med J India [Internet]. 35. Available from: https://doi.org/10.25259/NMJI_419_19
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Journal of Advance Research in Medical & Health Science (ISSN: 2208-2425)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
